Home NDC 70529-254 Venipuncture Px1
Product NDC 70529-254
11-digit product format 705290254
Labeler code 70529
Product ID 70529-254_09438de7-c42a-4581-a019-9e67f83187b3
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Lidocaine Hydrochloride
Dosage form KIT
Labeler IT3 Medical LLC
Application ANDA040433
Marketing category ANDA
Marketing start 2016-05-01
Marketing end 0000-00-00
Active strength 0
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 30 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 70529-254-01 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 70529-254-01 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 70529-254-01 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 70529-254-01 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 70529-254-01 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 70529-254-01 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 70529-254-01 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 70529-254-01 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 70529-254-01 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 70529-254-01 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 70529-254-01 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 70529-254-01 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 70529-254-01 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 70529-254-01 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 70529-254-01 1332a3947898…d4bfe170f9cd…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A040433-001 LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A040433-001 AT
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT RS 2003-02-12 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT RS 2003-02-12 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT RS 2003-02-12 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT RS 2003-02-12 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT RS 2003-02-12 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT RS 2003-02-12 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT RS 2003-02-12 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT 2003-02-12 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT RS 2003-02-12 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT RS 2003-02-12 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT RS 2003-02-12 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT RS 2003-02-12 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT RS 2003-02-12 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A040433-001 LIDOCAINE HYDROCHLORIDE 2% JELLY / TOPICAL AT RS 2003-02-12 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 67777-121-13 Venipuncture Px1 0.55 mL in 1 POUCH SWAB 1.1 mL 0.7 mL in 1mL 4 70529-254-01 Venipuncture Px1 1 in 1 KIT KIT 1 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70529-254 VENIPUNCTURE PX1 (LIDOCAINE HYDROCHLORIDE) KIT [IT3 MEDICAL LLC] 4 Legacy NDC, 2 package rows 20220302_a76e1cee-f89e-481e-adcc-0a4e3414a8be.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Lidocaine LIDOCAINE HYDROCHLORIDE ARMAS PHARMACEUTICALS INC. 2f6e0f3d-ceaf-a853-e063-6394a90a8efb 2025-03-07 Warnings, Adverse reactions Exact identifier application applno (ANDA): 040433 application number: ANDA040433
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 67777-121-13 67777012113 0.55 mL in 1 POUCH 0.55 ml Historical 70529-254-01 70529025401 1 KIT in 1 KIT (70529-254-01) * 1 TUBE in 1 CARTON (17478-840-05) > 5 mL in 1 TUBE * .55 mL in 1 POUCH (67777-121-13) 1 kit 2016-05-01 0000-00-00 No No Current